Chao Wang

7PUBLICATIONS
8CO-AUTHORS
Innate immunityBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsGlycoconjugatesNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 06, 2025
Design of a highly potent bifunctional HIV-1 entry inhibitor targeting both gp120 and gp41.

Xinmeng Du, Qing Li, Shu Du

|Aug 22, 2025
Potent Inhibition of Human Betacoronaviruses by a Short Double-Stapled Peptide Mimicking the HR2 Core Region in Viral Spike Protein.

Chao Wang, Qing Li, Yuanzhou Wang

|Jun 18, 2024
Discovery of a Double-Stapled Short Peptide as a Long-Acting HIV-1 Inactivator with Potential for Oral Bioavailability.

Chao Wang, Wenpeng Zhang, Ling Xu

|Jul 15, 2021
A "Two-Birds-One-Stone" Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region.

Chao Wang, Xinling Wang, Huan Wang

|Sep 08, 2018
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.

Chao Wang, Lei Zhao, Shuai Xia

|Aug 10, 2018
De novo design of isopeptide bond-tethered triple-stranded coiled coils with exceptional resistance to unfolding and proteolysis: implication for developing antiviral therapeutics.

Chao Wang, Wenqing Lai, Fei Yu

Pageof 2

Frequent Collaborators

3 joint publications

Shibo Jiang

3 joint publications

Keliang Liu

3 joint publications

Shibo Jiang

2 joint publications

Yang Liu